Average Co-Inventor Count = 3.39
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (4 from 2,405 patents)
2. Mitobridge, Inc. (3 from 20 patents)
3. Schering Corporation (2 from 1,829 patents)
4. Aralez Pharmaceuticals Trading Dac (1 from 1 patent)
10 patents:
1. 11912681 - Crystalline and salt forms of PPAR agonist compounds
2. 11530192 - Crystalline and salt forms of PPAR agonist compounds
3. 10927094 - Crystalline and salt forms of PPAR agonist compounds
4. 10577348 - (S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
5. 10035796 - Crystalline forms of a BACE inhibitor, compositions, and their use
6. 10017505 - Crystalline forms of a BACE inhibitor, compositions, and their use
7. 9604971 - Co-crystal of the PAR-1 receptor antagonists vorapaxar and aspirin
8. 8680294 - Enantio- and stereo specific synthesis of β-amino-α-hydroxy amides
9. 7956189 - Maleate, tosylate, fumarate and oxalate salts of 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methoxy-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process therefore
10. 7919505 - Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound